Health
UCLH doses first patient in the world in Covid-19 antibody trial – University College London Hospitals
UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.
UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.
Researchers in the STORM CHASER study led by UCLH virologist Dr Catherine Houlihan recruited the first participant in the world to the study earlier this month and have recruited 10 participants to date.
They believe the antibody or LAAB, known as AZD7442 and developed by AstraZeneca, may offer immediate and long-term protection to people who have…
-
General10 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General22 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News16 hours agoFatal traffic crash, Baringa – Sunshine Coast
-
General12 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery